AWM Investment Company’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,200,000
Closed -$40.1M 99
2025
Q4
$40.1M Hold
2,200,000
3.88% 2
2025
Q3
$32.3M Hold
2,200,000
3.02% 7
2025
Q2
$40.1M Sell
2,200,000
-226,431
-9% -$4.62M 4.49% 3
2025
Q1
$48.1M Hold
2,426,431
6.63% 1
2024
Q4
$41.6M Sell
2,426,431
-2,026,246
-46% -$38.1M 5.07% 1
2024
Q3
$89M Sell
4,452,677
-644,948
-13% -$10M 10.78% 1
2024
Q2
$57M Sell
5,097,625
-617,257
-11% -$5.18M 7.7% 1
2024
Q1
$37.7M Sell
5,714,882
-284,990
-5% -$1.56M 4.94% 2
2023
Q4
$27.1M Hold
5,999,872
3.57% 6
2023
Q3
$21.5M Sell
5,999,872
-17,700
-0.3% -$68.1K 3.17% 4
2023
Q2
$22.2M Buy
6,017,572
+2,572
+0% +$9.53K 3.01% 6
2023
Q1
$19.9M Hold
6,015,000
2.69% 6
2022
Q4
$23.3M Buy
6,015,000
+1,000,000
+20% +$3.08M 3.37% 5
2022
Q3
$12.2M Hold
5,015,000
1.85% 13
2022
Q2
$9.93M Buy
5,015,000
+335,000
+7% +$659K 1.56% 23
2022
Q1
$8.56M Buy
4,680,000
+100,100
+2% +$156K 1.1% 29
2021
Q4
$6.46M Buy
+4,579,900
New +$6.02M 0.65% 47

Other funds holding ADMA

AWM Investment Company's ADMA Position: Q1 2026 in Review

AWM Investment Company sold out of ADMA Biologics (ADMA) in Q1 2026, closing a stake of 2,200,000 shares — an estimated $40.1M sold.

AWM Investment Company first reported a position in ADMA in Q4 2021 and held it in 17 quarters. The position peaked at $89M in Q3 2024. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • AWM Investment Company reported no remaining ADMA Biologics position as of Q1 2026 after selling out during the quarter.
  • AWM Investment Company sold 2,200,000 ADMA Biologics shares in Q1 2026, an estimated $40.1M.
  • AWM Investment Company first reported a position in ADMA Biologics in Q4 2021 and held it in 17 quarters.
  • AWM Investment Company's ADMA Biologics position peaked at $89M in Q3 2024.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on AWM Investment Company's 13F filing for Q1 2026, filed 15 May 2026.